|
RPN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.272810E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.236200E-01 |
| Normal-vs-Stage2 |
3.963000E-01 |
| Normal-vs-Stage3 |
6.285200E-01 |
| Normal-vs-Stage4 |
1.498000E-01 |
| Stage1-vs-Stage2 |
7.948800E-01 |
| Stage1-vs-Stage3 |
8.243600E-01 |
| Stage1-vs-Stage4 |
4.102000E-01 |
| Stage2-vs-Stage3 |
7.294200E-01 |
| Stage2-vs-Stage4 |
6.922800E-01 |
| Stage3-vs-Stage4 |
4.101600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.400400E-02 |
| Normal-vs-AfricanAmerican |
5.167400E-01 |
| Normal-vs-Asian |
9.764000E-01 |
| Caucasian-vs-AfricanAmerican |
8.245600E-02 |
| Caucasian-vs-Asian |
7.220200E-01 |
| AfricanAmerican-vs-Asian |
8.175000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.346400E-01 |
| Normal-vs-Female |
1.303780E-01 |
| Male-vs-Female |
7.560200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.554000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.645000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.784240E-01 |
| Normal-vs-Age(81-100Yrs) |
5.257800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.736200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.348400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.158000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.837200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.336200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.626400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.793800E-01 |
| Normal-vs-Grade 2 |
5.749000E-01 |
| Normal-vs-Grade 3 |
2.818800E-01 |
| Normal-vs-Grade 4 |
3.928000E-02 |
| Grade 1-vs-Grade 2 |
9.537600E-01 |
| Grade 1-vs-Grade 3 |
6.609600E-01 |
| Grade 1-vs-Grade 4 |
1.493950E-01 |
| Grade 2-vs-Grade 3 |
5.607200E-01 |
| Grade 2-vs-Grade 4 |
8.182100E-02 |
| Grade 3-vs-Grade 4 |
1.812840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.867200E-01 |
| Normal-vs-ccB subtype |
3.661500E-03 |
| ccA subtype-vs-ccB subtype |
4.836300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.170200E-02 |
| Normal-vs-N1 |
1.105590E-01 |
| N0-vs-N1 |
1.995400E-01 |
|
|
